Valeant Pharmaceuticals International Inc (NYSE:VRX)

18.88
Delayed Data
As of Feb 16
 +0.21 / +1.12%
Today’s Change
8.31
Today|||52-Week Range
24.43
-9.14%
Year-to-Date

Today’s Trading

Previous close18.67
Today’s open18.67
Day’s range18.60 - 19.09
Volume10,169,588
Average volume (3 months)16,469,283
Market cap$6.6B
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-716.47%
Earnings growth (this year)-30.02%
Earnings growth (next 5 years)+3.50%
Revenue growth (last year)-7.39%
P/E ratio4.8
Price/Sales0.52
Price/Book2.08

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV-1.40-1.20%
ACADACADIA Pharmaceutica...-0.14-0.45%
TAROTaro Pharmaceutical ...-0.29-0.28%
----
Data as of 4:01pm ET, 02/16/2018

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)$0.97
Annual revenue (last year)$9.7B
Annual profit (last year)-$2.4B
Net profit margin-24.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Qubec

Forecasts